[NBIX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
01-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 81.45%
YoY- 69.84%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 258,500 222,094 151,757 60,774 0 0 0 -
PBT -57,100 58,407 50,764 -11,125 -36,887 -34,435 -15,875 23.75%
Tax 500 4,618 7,672 7,337 -1,549 -1,409 -1,199 -
NP -57,600 53,789 50,764 -11,125 -36,887 -34,435 -15,875 23.93%
Tax Rate - -7.91% -15.11% - - - - -
Total Cost 316,100 168,305 100,993 71,899 36,887 34,435 15,875 64.55%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -22.28 24.22 33.45 -18.31 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.62 0.59 0.56 -0.13 -0.43 -0.40 -0.21 19.75%
EPS Diluted -0.62 0.56 0.52 -0.13 -0.43 -0.40 -0.21 19.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.